| Title | Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. | | Author(s) | Maurer SH, Wilimas JA, Wang WC, Reiss UM | | Institution | Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee. | | Source | Pediatr Blood Cancer 2009 May 4. | | Abstract | An 11-year-old female developed heparin induced thrombocytopenia (HIT) with thrombosis during therapy for lower extremity deep vein thrombosis and pulmonary embolism. Transition from bivalirudin, a direct thrombin inhibitor (DTI), to warfarin resulted in extensive re-thrombosis, and fondaparinux therapy similarly failed. She was then treated with argatroban, and transitioned successfully to warfarin after 9 weeks. The risk of re-thrombosis was ultimately reduced by allowing time for the thrombogenic potential to abate. The argatroban/warfarin transition was monitored with chromogenic factor X levels. This case highlights several difficult problems in pediatric thrombosis. Pediatr Blood Cancer (c) 2009 Wiley-Liss, Inc. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19415734 |
|
